Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
PHASE2
The study hypothesis is that a "reinforced" pneumococcal combined vaccine s...
Status
Completed
Location
Pôle de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques " Hôpital Cochin, Assistance Publique-Hôpitaux de Paris
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)
PHASE3
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Chinle Comprehensive Health Care Facility ( Site 0001)
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
PHASE4
The French Public Health Council recommended pneumococcal vaccination combi...